IBP

INSTALLED BUILDING PRODUCTS, INC.

$285.88

+0.08%
Apr 12, 2026
Bobby Quantitative Model
Installed Building Products, Inc. (IBP) is a leading installer of insulation and complementary building products, primarily serving the residential new construction market across the United States. The company operates as a consolidator and market leader in a fragmented industry, leveraging its national scale and diversified service offerings, including waterproofing, fireproofing, and garage door installation, to build a competitive moat. The current investor narrative is heavily influenced by the stock's significant outperformance relative to the broader market, driven by strong operational execution within the residential construction sector, though recent price volatility suggests debate over the sustainability of its growth trajectory and valuation amidst potential cyclical headwinds.

People also watch

D. R. Horton

D. R. Horton

DHI

Analysis
PulteGroup

PulteGroup

PHM

Analysis
Lennar Corporation

Lennar Corporation

LEN

Analysis
Toll Brothers

Toll Brothers

TOL

Analysis
Taylor Morrison

Taylor Morrison

TMHC

Analysis

BobbyInvestment Opinion: Should I buy IBP Today?

Rating & Thesis: Hold. IBP is a high-quality, cyclically-exposed operator trading at a full valuation, making it prudent to await a better entry point or clearer signs of sustained growth acceleration. The limited analyst coverage and absence of a consensus price target underscore the stock's niche status and associated uncertainty.

Supporting Evidence: The hold rating is anchored by four key data points: 1) a premium forward PE of 23.45x, 2) a high PEG ratio of 3.94 suggesting expensive growth, 3) exceptional ROE of 37.39% justifying a quality premium, and 4) strong price momentum (+67.80% 1-year) that may be exhausted in the near term. The stock's 2.35x Price-to-Sales ratio and 15.65x EV/EBITDA provide additional valuation context, though peer benchmarks are unavailable for definitive comparison.

Risks & Conditions: The two biggest risks are a housing slowdown compressing earnings and valuation multiple contraction due to its high beta. This Hold would upgrade to a Buy if the forward PE compressed toward 18x, if quarterly results demonstrate accelerating revenue growth, or if the stock establishes strong support above its March low of ~$258. Conversely, a downgrade to Sell would be warranted if net margins contract below 7%, debt levels rise significantly, or the price breaks decisively below the $258 support level. Based on available data, the stock appears fairly valued to slightly overvalued relative to its own growth profile, though it is priced for the quality indicated by its ROE.

Sign up to view all

IBP 12-Month Price Forecast

The outlook for IBP is one of high-quality operations trapped in a volatile, fully-valued stock. The exceptional ROE is a compelling reason to own the business, but the current price and high beta suggest most of the near-term upside may be captured. The neutral stance reflects this balance: the company's fundamentals are strong, but the risk/reward at current levels is not compelling. The stance would upgrade to bullish on a significant pullback (toward $250) that improves the margin of safety, or if upcoming earnings reports show accelerating top-line growth. It would turn bearish if technical support at $258 fails, signaling a breakdown in the long-term uptrend.

Historical Price
Current Price $285.88
Average Target $300
High Target $370
Low Target $200

Wall Street consensus

Most Wall Street analysts maintain a constructive view on INSTALLED BUILDING PRODUCTS, INC.'s 12-month outlook, with a consensus price target around $371.64 and implied upside of +30.0% versus the current price.

Average Target

$371.64

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$229 - $372

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage for IBP is limited, with only 3 analysts providing estimates, which is typical for a mid-cap company and can lead to higher volatility and less efficient price discovery. The consensus estimates point to an average EPS of $14.06 for the coming period, with a relatively narrow range from a low of $12.87 to a high of $15.03. Similarly, revenue estimates are tightly clustered around $3.37 billion. This tight range on estimates suggests a degree of conviction in the near-term financial outlook among the covering analysts. A full target price range and consensus recommendation are not available in the provided data. The absence of explicit price targets and buy/hold/sell ratings means we cannot calculate an implied upside/downside from the current price or gauge the overall bullish or bearish sentiment. The limited coverage itself is a key signal; it often indicates the stock may be under-followed by the broader institutional research community, which can create both opportunity and risk for investors.

Drowning in data?

Find the real signal!

Bulls vs Bears: IBP Investment Factors

The evidence tilts cautiously bullish, supported by IBP's exceptional operational efficiency (37.39% ROE), strong long-term momentum, and robust profitability. However, the bear case presents significant counterweights, primarily the stock's extreme volatility (beta 1.985) and rich valuation (PEG 3.94). The single most important tension in the investment debate is whether the company's superior capital allocation and market-leading position can sustainably justify its premium valuation in the face of inherent cyclicality and potential macroeconomic headwinds. The resolution of this tension—specifically, whether earnings growth can outpace multiple compression—will dictate the stock's future trajectory.

Bullish

  • Exceptional Return on Equity: IBP's ROE of 37.39% is exceptionally high, indicating superior capital efficiency and a strong competitive moat in its fragmented industry. This metric justifies a premium valuation and suggests the company can generate significant shareholder value from reinvested earnings.
  • Strong Long-Term Price Momentum: The stock has significantly outperformed the market with a 1-year price change of +67.80% versus the SPY's +29.52%. This powerful uptrend, from a 52-week low of $150.83 to a recent high of $349.00, reflects strong investor confidence in the company's execution and market leadership.
  • Robust Profitability Margins: The company maintains solid profitability with a net margin of 8.93% and an operating margin of 13.01%. A forward PE of 23.45x, lower than the trailing PE of 26.29x, implies analyst expectations for continued earnings growth, supporting the stock's premium multiple.
  • Healthy Balance Sheet Liquidity: A current ratio of 3.03 indicates strong short-term financial health and ample liquidity to navigate cyclical downturns or fund growth initiatives. This provides a buffer against operational risks inherent in the residential construction sector.

Bearish

  • High Cyclical and Market Risk: With a beta of 1.985, IBP is nearly twice as volatile as the broader market, amplifying downside risk during market corrections. The stock's recent 3-month decline of -3.56% and a 25.17% max drawdown from its 52-week high demonstrate this heightened sensitivity.
  • Expensive PEG Ratio: A PEG ratio of 3.94 suggests the stock is richly valued relative to its perceived growth rate, indicating investors may be overpaying for future earnings growth. This creates vulnerability to valuation compression if growth expectations are not met.
  • Moderate Financial Leverage: A debt-to-equity ratio of 1.48 indicates reliance on debt financing, which could pressure cash flow and limit flexibility if interest rates rise or earnings decline. This leverage increases financial risk in a cyclical downturn.
  • Limited Analyst Coverage: With only 3 analysts providing estimates, the stock suffers from lower visibility and potentially less efficient price discovery. The absence of explicit price targets and consensus ratings makes it harder to gauge market sentiment and implied upside/downside.

IBP Technical Analysis

The stock is in a powerful, sustained long-term uptrend, evidenced by a 1-year price change of +67.80%, significantly outpacing the SPY's +29.52% gain. Currently trading at $285.88, it sits approximately 82% of the way through its 52-week range ($150.83 to $349.00), indicating it is closer to its highs than lows, which reflects strong investor momentum but also raises questions about overextension. The stock's beta of 1.985 signals it is nearly twice as volatile as the market, a critical factor for risk-aware investors given its recent price swings. Recent momentum shows a stark divergence, with a strong 1-month gain of +1.62% contrasting with a 3-month decline of -3.56%. This suggests the longer-term uptrend has recently faced a corrective phase, though the positive one-month performance indicates a potential attempt at stabilization or recovery. The stock's 1-month relative strength of +1.16% against the SPY's +0.46% shows it is regaining leadership, but the 3-month relative strength of -1.46% confirms it has recently underperformed the broader market. Key technical support is anchored near the 52-week low of $150.83, though more immediate support is likely around the recent March low near $258.79. Primary resistance is at the 52-week high of $349.00. A decisive breakout above this level would signal a resumption of the primary bull trend, while a breakdown below the March low could indicate a deeper correction is underway. The high beta of 1.985 underscores that any market-wide moves will be amplified in IBP, necessitating careful position sizing.

Beta

1.99

1.99x market volatility

Max Drawdown

-25.2%

Largest decline past year

52-Week Range

$151-$349

Price range past year

Annual Return

+67.8%

Cumulative gain past year

PeriodIBP ReturnS&P 500
1m+1.6%+2.6%
3m-3.6%-2.3%
6m+19.5%+2.6%
1y+67.8%+27.3%
ytd+6.9%-0.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

IBP Fundamental Analysis

Revenue and growth trajectory analysis is constrained as specific quarterly revenue figures and year-over-year growth rates are not available in the provided dataset. The analyst consensus estimates an average annual revenue of approximately $3.37 billion, but without historical quarterly data, assessing acceleration or deceleration trends is not possible. This data gap limits the ability to pinpoint which business segments, such as Installation, Manufacturing, or Distribution, are the primary growth drivers. Profitability metrics are strong, with a net margin of 8.93% and a gross margin of 33.97%. The company is profitable, as indicated by positive trailing EPS of $0.038 and a forward PE ratio of 23.45x, which implies expectations of continued earnings. The operating margin of 13.01% provides insight into core operational efficiency, though the lack of sequential quarterly data prevents an analysis of margin expansion or compression trends over recent periods. The balance sheet exhibits moderate leverage with a debt-to-equity ratio of 1.48, which is manageable but indicates reliance on debt financing. Liquidity is robust with a current ratio of 3.03, suggesting strong short-term financial health. Return on Equity is exceptionally high at 37.39%, signaling very efficient use of shareholder capital. However, the absence of specific cash flow statement data (like Free Cash Flow) limits the assessment of internal funding capacity for growth versus dependence on external markets.

Quarterly Revenue

N/A

N/A

Revenue YoY Growth

N/A

YoY Comparison

Gross Margin

N/A

Latest Quarter

Free Cash Flow

N/A

Last 12 Months

Open an Account, get $2 TSLA now!

Valuation Analysis: Is IBP Overvalued?

Given the company's clear profitability (Net Income > 0), the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 26.29x, while the forward PE is lower at 23.45x. This forward discount suggests the market anticipates earnings growth, as future earnings are expected to be higher, thus lowering the multiple. The PEG ratio of 3.94, however, indicates the stock may be expensive relative to its perceived growth rate. Peer comparison is challenging as industry average multiples are not provided in the dataset. In isolation, a trailing PE of 26.29x and a Price-to-Sales ratio of 2.35x must be evaluated against the residential construction sector's typical ranges. Without this benchmark, we cannot definitively quantify a premium or discount, though the high ROE of 37.39% could justify an above-average multiple if sector peers are less efficient. Historical context is also limited due to the absence of provided historical valuation ratio data (e.g., 5-year PE range). Therefore, we cannot determine if the current trailing PE of 26.29x is near the top or bottom of its own historical band. This missing data point prevents a clear interpretation of whether the current valuation reflects peak optimism or presents a value opportunity relative to the company's own trading history.

PE

26.3x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

15.7x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: IBP's primary financial risk stems from its cyclical exposure to residential construction, where a downturn could pressure its 8.93% net margin and 13.01% operating margin. The company carries moderate leverage with a debt-to-equity ratio of 1.48, which, while manageable, increases interest expense sensitivity. Revenue concentration in new construction and the lack of detailed quarterly growth data obscure visibility into demand trends, making it difficult to assess the sustainability of current profitability levels that support its 26.29x trailing PE.

Market & Competitive Risks: The stock faces substantial valuation risk, trading at a forward PE of 23.45x and a PEG of 3.94, which leaves it vulnerable to multiple compression if growth slows or sector sentiment sours. Its high beta of 1.985 means it will disproportionately suffer in a broad market sell-off. As a consolidator in a fragmented industry, competitive pressures could intensify, potentially eroding its high ROE of 37.39%. Furthermore, limited analyst coverage (only 3 analysts) can lead to exaggerated price moves on news, increasing volatility.

Worst-Case Scenario: The most damaging scenario involves a sharp downturn in U.S. housing starts coupled with a broader market correction. This would trigger a double-whammy of declining earnings and compressed valuation multiples. Leverage would magnify the pain on the income statement. In this adverse scenario, the stock could realistically retrace to its 52-week low of $150.83, representing a potential loss of approximately -47% from the current price of $285.88. The recent 25.17% max drawdown from the 52-week high provides a recent precedent for significant downside volatility.

FAQ

The key risks are, in order of severity: 1) Cyclical/Macro Risk: High beta (1.985) and dependence on residential construction make the stock highly sensitive to interest rates and economic cycles. 2) Valuation Risk: A PEG of 3.94 creates vulnerability to multiple compression if growth slows. 3) Financial Risk: Moderate leverage (Debt/Equity of 1.48) could pressure cash flow in a downturn. 4) Liquidity/Visibility Risk: Limited analyst coverage (only 3 analysts) can lead to exaggerated price swings and less efficient price discovery.

The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $280 and $320, assuming stable housing demand and earnings meeting the $14.06 EPS consensus. The Bull Case (25% probability) targets $340-$370 on strong earnings beats and multiple expansion. The Bear Case (15% probability) warns of a drop to $200-$258 in a housing recession. The Base Case is most likely, hinging on the assumption that IBP's high ROE will provide a valuation floor despite cyclical volatility.

Based on available metrics, IBP appears fairly valued to slightly overvalued. The forward PE of 23.45x and trailing PE of 26.29x are not excessive for a company with a 37.39% ROE, which typically commands a premium. However, the high PEG ratio of 3.94 signals the market is paying a rich price for its growth expectations. Without direct peer comparisons or a long-term historical PE range, a definitive call is challenging, but the valuation implies the market expects strong, sustained earnings growth to continue, leaving little room for error.

IBP is a good buy for investors who understand and can tolerate high volatility (beta 1.985) and are seeking a high-quality operator within the cyclical housing sector. Its exceptional 37.39% ROE is a standout strength. However, at a forward PE of 23.45x and a PEG of 3.94, the stock is not cheap, and its 1-year rally of +67.80% suggests much optimism is already priced in. For most investors, it is not a good buy at the current level; waiting for a pullback toward stronger support (e.g., $250-$260) would improve the risk/reward profile significantly.

IBP is more suitable for a long-term investment horizon of 3-5 years, allowing investors to ride through the inherent volatility of the housing cycle and benefit from the company's consolidation strategy and high ROE. Its high beta of 1.985 and lack of a significant dividend (yield 1.26%) make it a poor candidate for short-term trading or income-seeking portfolios. A minimum holding period of 2-3 years is suggested to potentially realize the value of its operational excellence beyond near-term economic noise.